Trademarkia Logo

Australia

AU$
ACCULYSE
Published: Under examination

Last updated on 31 May 2025

Owner Info

Syncromune, Inc.

2919 East Commercial Blvd.

Fort Lauderdale FL 33308, UNITED STATES OF AMERICA

Serial Number

2454294 filed on 18 Mar 2024

Correspondent

Jessica L. Rothstein Goodwin Procter LLP

620 Eighth Avenue,

New York NY 10018,

UNITED STATES OF AMERICA

ACCULYSE

Classification Information


Class [010]
Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body Read More

Mark Details


Serial Number

2454294

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

2 Oct 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
31st May 2025IRDA - Opposition Still Possible Notice correspondence sent
27th Mar 2025Customer Amendment Made correspondence sent
26th Mar 2025Amendment to Address for Service Requested
1st Jun 2024Adverse Report (Examination) correspondence sent
31st May 2024IP Right has been Examined
30th May 2024Examination expedited
30th May 2024Awaiting examination
30th May 2024IP Right Filed Published
30th May 2024Status change to Published
30th May 2024Status change to Filed